Table 4.

Blood product support per patient among those with and without TT-CMV, normalized for 100 days of follow-up

Blood productTT-CMV,
n = 24
mean ± SE
No TT-CMV,
n = 783
mean ± SE
P
Total units4-150 55 ± 8 36 ± 2 .04  
Total CMV units 47 ± 7 34 ± 2 .17  
Total LR CMV+ units 7 ± 2 3 ± 0.3 .01  
 Filtered RBC from CMV+donor 0.9 ± 0.6 0.1 ± 0.04 .002  
 Filtered PLT from CMV+ donor 0.3 ± 0.2 0.3 ± 0.1 .92  
 LR Apheresis PLT from CMV+donor 6 ± 2 2 ± 0.2 .002 
Blood productTT-CMV,
n = 24
mean ± SE
No TT-CMV,
n = 783
mean ± SE
P
Total units4-150 55 ± 8 36 ± 2 .04  
Total CMV units 47 ± 7 34 ± 2 .17  
Total LR CMV+ units 7 ± 2 3 ± 0.3 .01  
 Filtered RBC from CMV+donor 0.9 ± 0.6 0.1 ± 0.04 .002  
 Filtered PLT from CMV+ donor 0.3 ± 0.2 0.3 ± 0.1 .92  
 LR Apheresis PLT from CMV+donor 6 ± 2 2 ± 0.2 .002 

CMV indicates cytomegalovirus; SE, standard error; LR, leukoreduced; RBC, red blood cell product; PLT, platelet product.

F4-150

Table reports units of product (ie, one unit from one donor). For pooled platelets, one “unit” represents pool of 6 random concentrates. CMV status of pool is positive if one unit in pool is positive or unknown.

Close Modal

or Create an Account

Close Modal
Close Modal